Lexatumumab
Lexatumumab ( also known as ETR2-ST01 ) is an experimental agonistic human monoclonal antibody against TRAIL-R2 ( DR5 , APO-2 ) , intended for the treatment of cancer . 
<triplet> Lexatumumab <subj> monoclonal antibody <obj> instance of